Oxybutynin is preferred to tolterodine for overactive bladderBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7422.0-f (Published 30 October 2003) Cite this as: BMJ 2003;327:0-f
Question Is extended release oxybutynin or tolterodine more effective and tolerable in women with an overactive bladder?
Synopsis Overactive bladder is characterised by symptoms of urinary urgency, and frequent micturitions with or without involuntary loss of urine (urge incontinence). This randomised controlled (double blinded) study, conducted in 71 centres in the United States, enrolled 790 older women with 21 to 60 urge urinary incontinence episodes per week and who urinated 10 or more times …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial